Collen D - Search Results

1

Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.

VandenDriessche T, Vanslembrouck V, Goovaerts I, Zwinnen H, Vanderhaeghen ML, Collen D, Chuah MK. VandenDriessche T, et al. Among authors: collen d. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10379-84. doi: 10.1073/pnas.96.18.10379. Proc Natl Acad Sci U S A. 1999. PMID: 10468616 Free PMC article.

2

Preclinical gene therapy studies for hemophilia using adenoviral vectors.

Thorrez L, VandenDriessche T, Collen D, Chuah MK. Thorrez L, et al. Among authors: collen d. Semin Thromb Hemost. 2004 Apr;30(2):173-83. doi: 10.1055/s-2004-825631. Semin Thromb Hemost. 2004. PMID: 15118929 Free article. Review.

3

Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.

Van Damme A, Chuah MK, Collen D, VandenDriessche T. Van Damme A, et al. Among authors: collen d. Semin Thromb Hemost. 2004 Apr;30(2):185-95. doi: 10.1055/s-2004-825632. Semin Thromb Hemost. 2004. PMID: 15118930 Review.

4

Clinical gene transfer studies for hemophilia A.

Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: collen d. Semin Thromb Hemost. 2004 Apr;30(2):249-56. doi: 10.1055/s-2004-825638. Semin Thromb Hemost. 2004. PMID: 15118936 Review.

5

Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice.

Chuah MK, Van Damme A, Zwinnen H, Goovaerts I, Vanslembrouck V, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: collen d. Hum Gene Ther. 2000 Mar 20;11(5):729-38. doi: 10.1089/10430340050015626. Hum Gene Ther. 2000. PMID: 10757352

6

Gene therapy for hemophilia.

Chuah MK, Collen D, VandenDriessche T. Chuah MK, et al. Among authors: collen d. J Gene Med. 2001 Jan-Feb;3(1):3-20. doi: 10.1002/1521-2254(200101/02)3:1<3::AID-JGM167>3.0.CO;2-H. J Gene Med. 2001. PMID: 11269333 Review.

7

Viral vector-mediated gene therapy for hemophilia.

VandenDriessche T, Collen D, Chuah MK. VandenDriessche T, et al. Among authors: collen d. Curr Gene Ther. 2001 Sep;1(3):301-15. doi: 10.2174/1566523013348508. Curr Gene Ther. 2001. PMID: 12109144 Review.

8

Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats.

Van Damme A, Chuah MK, Dell'accio F, De Bari C, Luyten F, Collen D, VandenDriessche T. Van Damme A, et al. Among authors: collen d. Haemophilia. 2003 Jan;9(1):94-103. doi: 10.1046/j.1365-2516.2003.00709.x. Haemophilia. 2003. PMID: 12558785

9

Gene therapy for the hemophilias.

VandenDriessche T, Collen D, Chuah MK. VandenDriessche T, et al. Among authors: collen d. J Thromb Haemost. 2003 Jul;1(7):1550-8. doi: 10.1046/j.1538-7836.2003.00265.x. J Thromb Haemost. 2003. PMID: 12871290 Free article. Review.

10

Preclinical and clinical gene therapy for haemophilia.

Chuah MK, Collen D, Vandendriessche T. Chuah MK, et al. Among authors: collen d. Haemophilia. 2004 Oct;10 Suppl 4:119-25. doi: 10.1111/j.1365-2516.2004.00984.x. Haemophilia. 2004. PMID: 15479384 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

812 results

Search Page

Filters